- Stay Connected
Breaking News
All The Latest News Around Your Corner
Stocks
Keep Updated And Never Miss A Beat
FDA Rejects Dapagliflozin for Type 2 Diabetes – MedPage Today
 Updated News |
FDA Rejects Dapagliflozin for Type 2 Diabetes
MedPage Today By Emily P. Walker, Washington Correspondent, MedPage Today WASHINGTON — The FDA said it would not approve the novel diabetes drug dapagliflozin until drugmakers Bristol-Myers Squibb and AstraZeneca supply more data on the drug's benefits and risks. … FDA rejects dapagliflozin for diabetes, raising concerns for a class A Good News-Bad News Night for Bristol's Diabetes and Hepatitis Drugs AM Vitals: FDA Wants More Data on Diabetes Drug from Bristol-Myers, AstraZeneca |
You must be logged in to post a comment Login